tiprankstipranks
Advertisement
Advertisement

Biome Australia Director Increases Indirect Shareholding via On-Market Purchase

Story Highlights
  • Biome Australia director Geoffrey Sam disclosed an on-market purchase increasing his indirect shareholding through a family entity.
  • The acquisition adds 80,000 shares to Sam’s existing stake, maintains transparency in insider ownership, and involves no contract changes.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Biome Australia Director Increases Indirect Shareholding via On-Market Purchase

Claim 55% Off TipRanks

Biome Australia Ltd ( (AU:BIO) ) just unveiled an update.

Biome Australia Limited has reported a change in the indirect interests of director Geoffrey Sam in the company’s shares, in line with ASX listing rule requirements. The disclosure highlights the director’s holdings through family-related entities, underscoring ongoing transparency around insider ownership for investors.

Sam, through Burrangong Pty Ltd as trustee of the Sam Family Settlement, acquired 80,000 fully paid ordinary shares on market on 28 April 2026 for $24,099.08, increasing that holding to 6,079,512 shares while his superannuation-related holding remained unchanged at 343,025 shares. The transaction did not occur during a closed period, and there were no changes to interests in contracts, indicating a straightforward on-market purchase rather than a structural or governance-related shift.

The most recent analyst rating on (AU:BIO) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.

More about Biome Australia Ltd

Biome Australia Limited is an Australian company listed on the ASX. While the release does not specify its sector, it operates as a publicly traded entity subject to ASX disclosure rules and director interest reporting requirements.

Average Trading Volume: 190,190

Technical Sentiment Signal: Hold

Current Market Cap: A$74.1M

For a thorough assessment of BIO stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1